Quantcast

Subscribe to:
POZ magazine
E-newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:
Welcome, Guest. Please login or register.
September 30, 2014, 07:00:16 PM

Login with username, password and session length


Members
Stats
  • Total Posts: 640605
  • Total Topics: 48657
  • Online Today: 240
  • Online Ever: 585
  • (January 07, 2014, 02:31:47 PM)
Users Online

Welcome


Welcome to the POZ/AIDSmeds Community Forums, a round-the-clock discussion area for people with HIV/AIDS, their friends/family/caregivers, and others concerned about HIV/AIDS.  Click on the links below to browse our various forums; scroll down for a glance at the most recent posts; or join in the conversation yourself by registering on the left side of this page.

Privacy Warning:  Please realize that these forums are open to all, and are fully searchable via Google and other search engines. If you are HIV positive and disclose this in our forums, then it is almost the same thing as telling the whole world (or at least the World Wide Web). If this concerns you, then do not use a username or avatar that are self-identifying in any way. We do not allow the deletion of anything you post in these forums, so think before you post.

  • The information shared in these forums, by moderators and members, is designed to complement, not replace, the relationship between an individual and his/her own physician.

  • All members of these forums are, by default, not considered to be licensed medical providers. If otherwise, users must clearly define themselves as such.

  • Forums members must behave at all times with respect and honesty. Posting guidelines, including time-out and banning policies, have been established by the moderators of these forums. Click here for “Am I Infected?” posting guidelines. Click here for posting guidelines pertaining to all other POZ/AIDSmeds community forums.

  • We ask all forums members to provide references for health/medical/scientific information they provide, when it is not a personal experience being discussed. Please provide hyperlinks with full URLs or full citations of published works not available via the Internet. Additionally, all forums members must post information which are true and correct to their knowledge.

  • Product advertisement—including links; banners; editorial content; and clinical trial, study or survey participation—is strictly prohibited by forums members unless permission has been secured from POZ.

To change forums navigation language settings, click here (members only), Register now

Para cambiar sus preferencias de los foros en español, haz clic aquí (sólo miembros), Regístrate ahora

Finished Reading This? You can collapse this or any other box on this page by clicking the symbol in each box.

Author Topic: Gilead subpoena over quality of Atripla  (Read 1184 times)

0 Members and 1 Guest are viewing this topic.

Offline mikeyb39

  • Member
  • Posts: 933
Gilead subpoena over quality of Atripla
« on: June 27, 2011, 10:35:54 AM »



Gilead Sciences Receives Subpoena from U.S. Department of Justice reguarding the QUALITY of Atripla
Jun 12, 2011

The following press release was made on 6/10/11 from Gilead and it involves Atripla. The QUALITY of Atripla is being investigated by the US Department of Justice and I would like more information than what Gilead has conveniently timed to put out late Friday (the 1st press release forgot the word "QUALITY" as being investigated.) What issues have been raised, what concerns should we have as people who are taking this drug? Gilead should be required to immediately come clean on what they know and what they are doing to make things right.

FOSTER CITY, Calif.--(BUSINESS WIRE)--June 10, 2011--

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has received a subpoena from the United States Attorney's Office for the Northern District of California requesting documents related to the manufacture, and related quality and distribution practices, of Atripla(R) , Emtriva(R) , Hepsera(R) , Letairis(R) , Truvada(R) , Viread(R) and our investigational fixed-dose combination of Truvada and Edurant(TM) . Gilead is cooperating in this civil and criminal investigation.

11/02/2010  cd4-251, vl-591000
12/09/2010  started Atripla
02/18/2011  cd4-425, vl-800
06/10/2011  cd4-447, vl-70
10/10/2011  cd4-666, vl-80
01/05/2012  swiched med (prezista,norvir ,isentress, )
02/10/2012  cd4-733, vl-UD  Viread removed
06/10/2012  cd4-614, vl-UD
12/14/2012  cd4-764, vl-UD
09/01/2013  cd4-785, vl-UD
03/06/2014. cd4- 1078, VL-UD
09/05/2014  cd4-850 , VL-UD

Offline Billy B

  • Member
  • Posts: 374
Re: Gilead subpoena over quality of Atripla
« Reply #1 on: June 27, 2011, 10:41:11 AM »


Gilead Sciences Receives Subpoena from U.S. Department of Justice reguarding the QUALITY of Atripla
Jun 12, 2011

The following press release was made on 6/10/11 from Gilead and it involves Atripla. The QUALITY of Atripla is being investigated by the US Department of Justice and I would like more information than what Gilead has conveniently timed to put out late Friday (the 1st press release forgot the word "QUALITY" as being investigated.) What issues have been raised, what concerns should we have as people who are taking this drug? Gilead should be required to immediately come clean on what they know and what they are doing to make things right.

FOSTER CITY, Calif.--(BUSINESS WIRE)--June 10, 2011--

Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has received a subpoena from the United States Attorney's Office for the Northern District of California requesting documents related to the manufacture, and related quality and distribution practices, of Atripla(R) , Emtriva(R) , Hepsera(R) , Letairis(R) , Truvada(R) , Viread(R) and our investigational fixed-dose combination of Truvada and Edurant(TM) . Gilead is cooperating in this civil and criminal investigation.




Hello Mikey-  Any idea what is wrong?
Peace,
Billy
VL 4420 CD4 340 CD4% 24   3/15/10 Started I&T
VL  UD   CD4 340 CD4% 26.5 05/13/10
VL  UD   CD4 360 CD4% 27.1 08/3/10
VL  UD   CD4 310 CD4% 28.4 11/22/10
VL  UD   CD4 420 CD4% 27.9 02/11/11
VL  UD   CD4 370 CD4% 26.4 06/08/11
VL  UD   CD4 360 CD4% 27.7 09/23/11
VL  UD   CD4 370 CD4% 28.3 01/20/12
VL  UD   CD4 430 CD4% 28.8 05/11/12
VL  UD   CD4 370 CD4% 28.1 09/07/12
VL  UD   CD4 390 CD4% 32.3 03/14/13

Offline mecch

  • Member
  • Posts: 11,766
  • red pill? or blue pill?
Re: Gilead subpoena over quality of Atripla
« Reply #2 on: June 27, 2011, 11:07:38 AM »
Gee for the price you expect Cartier quality.

But actually, a classic Cartier tank watch is a mediocre product marked up a million times. The movement is worth a couple hundred bucks tops.

PS - isn't there already a thread about this somewhere?
“From each, according to his ability; to each, according to his need” 1875 K Marx

Offline gerry69

  • Member
  • Posts: 23
Re: Gilead subpoena over quality of Atripla
« Reply #3 on: June 27, 2011, 07:24:58 PM »
Here is link to a post referencing the subpoena while it fails to clarify the nature of the request it does seem to say it is a separate matter from those for which Gilead received earlier subpoenas.

"In December 2006, concerning marketing and medical education programs for Truvada, Viread and Emtriva; and in 2009, for sales and marketing of Ranexa. However, he pointed out that both investigations were resolved without any penalty."

http://www.pharmalot.com/2011/06/gilead-gets-subpoena-from-justice-department/

Additionally there is a post on The Body.com

http://www.thebody.com/Forums/AIDS/Meds/Q215566.html

with reassurances that in so far as little is known at this time with relation to the nature of the investigation
"so long as routine medical and laboratory monitoring has not raised any signals of side effects or toxicity, I'd not be overly concerned."




 


Terms of Membership for these forums
 

© 2014 Smart + Strong. All Rights Reserved.   terms of use and your privacy
Smart + Strong® is a registered trademark of CDM Publishing, LLC.